| Dr Terrence Mathew Welsh, MD | |
|
175 Morristown Rd, Suite 202, Basking Ridge, NJ 07920-1655 | |
| (908) 630-0175 | |
| Not Available |
| Full Name | Dr Terrence Mathew Welsh |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 18 Years |
| Location | 175 Morristown Rd, Basking Ridge, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821231135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 247701 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Medical Center | Morristown, NJ | Hospital |
| Overlook Medical Center | Summit, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlantic Neurosurgical Specialists Pa | 7517951866 | 35 |
| Maxim Brain And Spine | 1557712981 | 11 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.
Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.
Californian researchers are trying to create an artificial testicle that will produce human sperm. Dr. Paul Turek, director of the Turek Clinic in San Francisco, which specializes in male infertility, said the goal is not to create a testicular implant for men, but a "sperm-making biological machine" that will help scientists learn more about just what causes male infertility. "We're trying to recreate the process of sperm production in a three-dimensional system," Turek said. "Simple laboratory conditions can't get it done in humans. Our concept is to actually recreate the testicle itself."
Centene Corporation announced today that the Florida Agency for Health Care Administration posted its notice of intent to award a contract for the Managed Medical Assistance program to Centene's Florida subsidiary Sunshine State Health Plan.
› Verified 3 days ago
| Entity Name | New Jersey Pain Consultants Pc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366448979 PECOS PAC ID: 6204749989 Enrollment ID: O20031110000090 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.
Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.
Californian researchers are trying to create an artificial testicle that will produce human sperm. Dr. Paul Turek, director of the Turek Clinic in San Francisco, which specializes in male infertility, said the goal is not to create a testicular implant for men, but a "sperm-making biological machine" that will help scientists learn more about just what causes male infertility. "We're trying to recreate the process of sperm production in a three-dimensional system," Turek said. "Simple laboratory conditions can't get it done in humans. Our concept is to actually recreate the testicle itself."
Centene Corporation announced today that the Florida Agency for Health Care Administration posted its notice of intent to award a contract for the Managed Medical Assistance program to Centene's Florida subsidiary Sunshine State Health Plan.
› Verified 3 days ago
| Entity Name | Atlantic Neurosurgical Specialists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568553287 PECOS PAC ID: 7517951866 Enrollment ID: O20040412000283 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.
Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.
Californian researchers are trying to create an artificial testicle that will produce human sperm. Dr. Paul Turek, director of the Turek Clinic in San Francisco, which specializes in male infertility, said the goal is not to create a testicular implant for men, but a "sperm-making biological machine" that will help scientists learn more about just what causes male infertility. "We're trying to recreate the process of sperm production in a three-dimensional system," Turek said. "Simple laboratory conditions can't get it done in humans. Our concept is to actually recreate the testicle itself."
Centene Corporation announced today that the Florida Agency for Health Care Administration posted its notice of intent to award a contract for the Managed Medical Assistance program to Centene's Florida subsidiary Sunshine State Health Plan.
› Verified 3 days ago
| Entity Name | Maxim Brain And Spine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184326621 PECOS PAC ID: 1557712981 Enrollment ID: O20240110000311 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.
Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.
Californian researchers are trying to create an artificial testicle that will produce human sperm. Dr. Paul Turek, director of the Turek Clinic in San Francisco, which specializes in male infertility, said the goal is not to create a testicular implant for men, but a "sperm-making biological machine" that will help scientists learn more about just what causes male infertility. "We're trying to recreate the process of sperm production in a three-dimensional system," Turek said. "Simple laboratory conditions can't get it done in humans. Our concept is to actually recreate the testicle itself."
Centene Corporation announced today that the Florida Agency for Health Care Administration posted its notice of intent to award a contract for the Managed Medical Assistance program to Centene's Florida subsidiary Sunshine State Health Plan.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terrence Mathew Welsh, MD 175 Morristown Rd, Suite 202, Basking Ridge, NJ 07920-1655 Ph: (908) 630-0175 | Dr Terrence Mathew Welsh, MD 175 Morristown Rd, Suite 202, Basking Ridge, NJ 07920-1655 Ph: (908) 630-0175 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.
Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.
Californian researchers are trying to create an artificial testicle that will produce human sperm. Dr. Paul Turek, director of the Turek Clinic in San Francisco, which specializes in male infertility, said the goal is not to create a testicular implant for men, but a "sperm-making biological machine" that will help scientists learn more about just what causes male infertility. "We're trying to recreate the process of sperm production in a three-dimensional system," Turek said. "Simple laboratory conditions can't get it done in humans. Our concept is to actually recreate the testicle itself."
Centene Corporation announced today that the Florida Agency for Health Care Administration posted its notice of intent to award a contract for the Managed Medical Assistance program to Centene's Florida subsidiary Sunshine State Health Plan.
› Verified 3 days ago